FY2027 EPS Forecast for McKesson Decreased by Analyst

McKesson Co. (NYSE:MCK) – Investment analysts at Leerink Partnrs lowered their FY2027 earnings per share estimates for McKesson in a note issued to investors on Wednesday, April 2nd. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings per share of $41.75 for the year, down from their prior forecast of $41.98. The consensus estimate for McKesson’s current full-year earnings is $32.77 per share. Leerink Partnrs also issued estimates for McKesson’s FY2027 earnings at $41.75 EPS.

McKesson (NYSE:MCK) last announced its earnings results on Wednesday, February 5th. The company reported $8.03 EPS for the quarter, missing the consensus estimate of $8.60 by ($0.57). McKesson had a negative return on equity of 181.26% and a net margin of 0.82%.

A number of other equities analysts have also recently issued reports on MCK. Citigroup lowered their target price on McKesson from $713.00 to $677.00 and set a “buy” rating for the company in a report on Friday, January 10th. Bank of America decreased their price objective on McKesson from $680.00 to $650.00 and set a “buy” rating for the company in a report on Monday, January 6th. StockNews.com downgraded shares of McKesson from a “strong-buy” rating to a “buy” rating in a report on Friday, February 14th. Mizuho lifted their price target on shares of McKesson from $630.00 to $690.00 and gave the company a “neutral” rating in a research note on Thursday. Finally, Evercore ISI lifted their target price on McKesson from $650.00 to $675.00 and gave the company an “outperform” rating in a research report on Thursday, February 6th. Two research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $661.00.

McKesson Stock Down 4.8 %

Shares of MCK stock opened at $682.41 on Friday. The company has a market capitalization of $85.52 billion, a price-to-earnings ratio of 31.25, a P/E/G ratio of 1.29 and a beta of 0.49. McKesson has a 12-month low of $464.42 and a 12-month high of $728.32. The firm has a fifty day moving average of $633.37 and a 200-day moving average of $584.91.

Hedge Funds Weigh In On McKesson

Large investors have recently bought and sold shares of the company. Quent Capital LLC grew its position in shares of McKesson by 10.1% in the 1st quarter. Quent Capital LLC now owns 1,297 shares of the company’s stock valued at $873,000 after buying an additional 119 shares during the last quarter. Moody National Bank Trust Division grew its stake in McKesson by 0.9% in the first quarter. Moody National Bank Trust Division now owns 2,003 shares of the company’s stock valued at $1,348,000 after acquiring an additional 18 shares during the period. Versant Capital Management Inc raised its holdings in McKesson by 75.7% during the first quarter. Versant Capital Management Inc now owns 592 shares of the company’s stock worth $398,000 after buying an additional 255 shares during the last quarter. Central Pacific Bank Trust Division lifted its position in McKesson by 153.0% in the 1st quarter. Central Pacific Bank Trust Division now owns 2,535 shares of the company’s stock valued at $1,706,000 after acquiring an additional 1,533 shares in the last quarter. Finally, First Hawaiian Bank boosted its position in shares of McKesson by 55.0% during the first quarter. First Hawaiian Bank now owns 5,580 shares of the company’s stock valued at $3,755,000 after buying an additional 1,980 shares during the last quarter. 85.07% of the stock is currently owned by institutional investors.

Insider Transactions at McKesson

In other McKesson news, CEO Brian S. Tyler sold 8,961 shares of the stock in a transaction dated Friday, February 21st. The shares were sold at an average price of $597.99, for a total transaction of $5,358,588.39. Following the sale, the chief executive officer now directly owns 60,664 shares in the company, valued at $36,276,465.36. This represents a 12.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Leann B. Smith sold 188 shares of the company’s stock in a transaction on Wednesday, February 12th. The stock was sold at an average price of $609.59, for a total value of $114,602.92. Following the sale, the executive vice president now owns 1,051 shares of the company’s stock, valued at $640,679.09. The trade was a 15.17 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 18,110 shares of company stock worth $10,855,706. Company insiders own 0.11% of the company’s stock.

McKesson Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, April 1st. Investors of record on Monday, March 3rd were issued a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend was Monday, March 3rd. McKesson’s payout ratio is 13.00%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.